David Novack - Aug 23, 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Signature
David Novack, by /s/ Justin Burgess, Attorney-in-Fact
Stock symbol
DVAX
Transactions as of
Aug 23, 2021
Transactions value $
-$112,770
Form type
4
Date filed
8/25/2021, 07:35 PM
Previous filing
Aug 13, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Award $8.48K +2.5K +2.33% $3.39* 110K Aug 13, 2021 Direct F1
transaction DVAX Common Stock Options Exercise $18.8K +4.17K +3.79% $4.50 114K Aug 23, 2021 Direct
transaction DVAX Common Stock Sale -$140K -10K -8.77% $14.00 104K Aug 24, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Warrant (Right to Buy) Options Exercise -4.17K -100% 0 Aug 23, 2021 Common Stock 4.17K $4.50 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021
F2 The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
F3 All shares were sold at $14.00
F4 Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance and have an expiration date of February 12, 2022.
F5 Not applicable